Search

Home > The Bio Report > Addressing the Challenge of Producing Stem Cell Therapies with Consistency at Scale
Podcast: The Bio Report
Episode:

Addressing the Challenge of Producing Stem Cell Therapies with Consistency at Scale

Category: Business
Duration: 00:29:23
Publish Date: 2019-06-13 16:05:50
Description: Mesenchymal stem cells may be a powerful way to treat a range of medical conditions but realizing the therapeutic potential of these cells has been hampered in part by the challenges of manufacturing a consistent product at scale. Cynata Therapeutics believes its platform technology addresses these challenges. The company lead cell therapy candidate is being developed to treat graft vs. host disease, a potentially deadly response to the transplantation of cells from a donor. We spoke to Ross MacDonald, CEO of Cynata, about the company’s platform technology, the potential for these therapies, and the indications the company is pursuing.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes